Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed
Cadila Pharmaceuticals, one of the leading research-based pharmaceutical companies in India, has now launched Dlorfast-M Tablets. It is a new fixed-dose combination tablet that contains 5 mg of Desloratadine (a novel antihistamine) and 10 mg...
Hikal Ltd., a long-term reliable partner to top global life sciences companies, has opened its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the Integrated Innovation Centre in Pune.
In a significant regulatory action against substandard goods, the Government of India has made an immediate announcement and imposed price-based import restrictions on substandard Sulfadiazine API. This speculation comes with an effective date...
Eli Lilly today announced it will present clinical data on Verzenio and multiple novel pipeline updates at the 2025 ESMO Annual Meeting in Berlin from October 17-21. The new data includes updates from across Lilly’s oncology portfolio as...
The Department of Psychiatry of the National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, stated that the National Faculty Development Programme (FDP) in Psychiatry will begin in 2026
India's Natco Pharma has stated its intention to buy a substantial proportion of shares of the South African pharmaceutical leader Adcock Ingram.
.png "Max Healthcare Plans Rs 5,000 Cr Capex to Add 4,200 Beds by FY28")
Max Healthcare is preparing for significant growth, and plans to spend more than ?5,000 crore in capital expenditure over the next three to four years, Managing Director Abhay Soi shared in an exclusive interview.The investment will be...
Samsung Biologics, a major global contract development and manufacturing organization (CDMO), has introduced ExellenS, a redesigned manufacturing framework
Merck, referred to as MSD outside the US and Canada, has declared that it will unveil the latest data concerning its pipeline for HIV treatment and prevention at the 20th European AIDS Conference
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")